Best Pharmaceutical Stocks To Watch Today - June 23rd

Eli Lilly and Company, Novo Nordisk A/S, Merck & Co., Inc., IQVIA, and D-Wave Quantum are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved in researching, developing, manufacturing and marketing medications and related healthcare products. Their value is often driven by factors such as clinical trial outcomes, regulatory approvals, patent expirations and changes in healthcare policy. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

LLY traded up $5.95 during trading on Monday, reaching $768.68. The stock had a trading volume of 2,076,874 shares, compared to its average volume of 3,662,494. The stock has a market cap of $728.51 billion, a PE ratio of 62.54, a PEG ratio of 1.11 and a beta of 0.41. The business has a 50-day moving average of $780.48 and a 200-day moving average of $800.76. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.06 and a current ratio of 1.37. Eli Lilly and Company has a one year low of $677.09 and a one year high of $972.53.

Read Our Latest Research Report on LLY

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NVO stock traded down $4.30 during mid-day trading on Monday, reaching $69.47. 11,686,341 shares of the company's stock traded hands, compared to its average volume of 7,133,156. Novo Nordisk A/S has a 12 month low of $57.00 and a 12 month high of $148.15. The company's 50-day moving average price is $68.41 and its 200-day moving average price is $78.27. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.56 and a current ratio of 0.74.

Read Our Latest Research Report on NVO

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of NYSE:MRK traded up $0.54 during midday trading on Monday, reaching $79.60. 7,110,317 shares of the company's stock traded hands, compared to its average volume of 13,019,410. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.41. The stock has a 50 day moving average of $78.89 and a 200 day moving average of $88.32. Merck & Co., Inc. has a one year low of $73.31 and a one year high of $134.63. The company has a market cap of $199.87 billion, a price-to-earnings ratio of 11.58, a P/E/G ratio of 0.82 and a beta of 0.38.

Read Our Latest Research Report on MRK

IQVIA (IQV)

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Shares of IQVIA stock traded up $0.71 on Monday, hitting $155.44. 3,413,621 shares of the company's stock were exchanged, compared to its average volume of 1,643,186. The company has a debt-to-equity ratio of 2.19, a quick ratio of 0.82 and a current ratio of 0.82. The company has a 50-day simple moving average of $148.21 and a 200-day simple moving average of $175.74. The stock has a market capitalization of $26.89 billion, a PE ratio of 21.17, a PEG ratio of 1.69 and a beta of 1.28. IQVIA has a 1 year low of $134.65 and a 1 year high of $252.88.

Read Our Latest Research Report on IQV

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

QBTS traded down $0.92 during trading on Monday, reaching $14.73. 33,512,635 shares of the company traded hands, compared to its average volume of 46,740,473. The company has a debt-to-equity ratio of 0.15, a quick ratio of 20.61 and a current ratio of 20.73. The company has a market cap of $4.30 billion, a P/E ratio of -24.54 and a beta of 1.48. The firm has a fifty day simple moving average of $12.41 and a 200 day simple moving average of $8.76. D-Wave Quantum has a 12-month low of $0.75 and a 12-month high of $19.77.

Read Our Latest Research Report on QBTS